Wesley J. Smith
Wesley J. Smith is a San Francisco-based attorney, columnist and anti-euthanasia activist. He is the author of Forced Exit: The Slippery Slope from Assisted Suicide to Legalized Murder (Times Books/Random House, 1997).
Wesley J. Smith is a San Francisco-based attorney, columnist and anti-euthanasia activist. He is the author of Forced Exit: The Slippery Slope from Assisted Suicide to Legalized Murder (Times Books/Random House, 1997).
Margaret Pabst Battin is a philosophy professor at the University of Utah and a leading figure in the public debate on end-of-life issues. She has written extensively on religious and ethical concerns in physician-assisted suicide and euthanasia and has researched active euthanasia and assisted suicide in the Netherlands. Her books include Ending Life: Ethics and the […]
Dr. Robert Brody is a professor of medicine at the University of California at San Francisco and chief of the Pain Consultation Clinic at San Francisco General Hospital. A former hospice director, he is a Compassion & Choices board member.
Barbara Coombs Lee is chief petitioner of Oregon’s Death with Dignity Act. She is the president of Compassion & Choices, formed when the Compassion in Dying Federation, based in Portland, merged with End-of-Life Choices, formerly known as the Hemlock Society.
Timothy Quill, a professor of medicine, psychiatry and palliative care at the University of Rochester School of Medicine, was the lead physician plaintiff in the 1977 New York state legal case challenging the prohibition of physician-assisted suicide. He is co-editor of Physician-Assisted Dying: The Case for Palliative Care and Patient Choice and author of Caring for Patients at […]
May 22, 2013, CBSNews.com article about an experimental asthma drug that has had success treating previously untreatable patients.
June 9, 2013, Las Vegas Review-Journal article about Dr. Nicholas Vogelzang who has brought several experimental drugs to Las Vegas.
May 31, 2013, WebMD article about new experimental drugs that are proving successful against prostate cancer.
June 6, 2013, The New York Times article about an experimental autism drug that had success in clinical trials but is now being discontinued.